Switching from efavirenz/emtricitabine/tenofovir (EFV/FTC/ TDF) or rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF) to rilpivirine/emtricitabine/ tenofovir alafenamide (RPV/FTC/TAF): Safety and efficacy through 48 weeks

This article has no abstract
Epistemonikos ID: e30ee1f31a77f25a6463955121eeac26e63d88bd
First added on: Feb 08, 2025